Oracle ended its fiscal third quarter with $553 billion in remaining purchase obligations -- up 325% year over year.

While there is a big gap between Meta Platforms and Oracle's market caps right now, the latter can still overtake the social media giant.

Clinical trial datasets are becoming increasingly complex, yet the format of their dissemination remains largely static.1 ...